Delivery Order SPE2DB24D3013-SPE2DB26FFGFD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $57,542.31 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA, leveraging the company's position as a critical healthcare solutions provider. The award is structured as a child...
- The Defense Logistics Agency awarded a delivery order valued at $11,671.95 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- The Defense Logistics Agency awarded a delivery order valued at $58,639.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 11, 2025. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $7,656.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $42,738.51 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of November 5, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,077.05 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $82,931.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical supply transaction under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a $11,424.62 delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This non-competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,400.47 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,837.84 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The product will be delivered to the company's corporate headquarters in Conshohocken,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGFDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,753.42 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 6, 2025, with completion scheduled for November 7, 2025. This non-competitive, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent is a specialty medication used in the treatment of atopic dermatitis, eosinophilic esophagitis, and other inflammatory conditions. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical devices distributed across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 11/6/25 |